Proprietary AI analyst is now available
- Public Comps
- Fifty 1 Labs
Fifty 1 Labs Valuation Multiples
Discover Fifty 1 Labs' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Crona, NxGen Brands, Olymp, Nosium and more.
Fifty 1 Labs Overview
About Fifty 1 Labs
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.
Founded
1998
HQ

Employees
10
Website
Financials (FY)
EV
$554K
Valuation Multiples
Start free trialFifty 1 Labs Financials
Fifty 1 Labs reported last fiscal year revenue of $0K and negative EBITDA of ($1K).
In the same fiscal year, Fifty 1 Labs generated $0K in gross profit, ($1K) in EBITDA losses, and had net loss of ($1K).
Fifty 1 Labs P&L
In the most recent fiscal year, Fifty 1 Labs reported revenue of $0K and EBITDA of ($1K).
Fifty 1 Labs is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of (1733%), and net margin of (1733%).
Financial data powered by Morningstar, Inc.
Fifty 1 Labs Stock Performance
Fifty 1 Labs has current market cap of $489K, and enterprise value of $554K.
Fifty 1 Labs' stock price is $0.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $554K | $489K | 0.0% | - | - | - | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFifty 1 Labs Valuation Multiples
Fifty 1 Labs trades at 7690.3x EV/Revenue multiple, and (443.7x) EV/EBITDA.
Fifty 1 Labs Financial Valuation Multiples
As of June 24, 2026, Fifty 1 Labs has market cap of $489K and EV of $554K.
Fifty 1 Labs has a P/E ratio of (391.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fifty 1 Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Fifty 1 Labs Margins & Growth Rates
In the most recent fiscal year, Fifty 1 Labs reported gross margin of 18%, EBITDA margin of (1733%), and net margin of (1733%).
Fifty 1 Labs Margins
Fifty 1 Labs Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Fifty 1 Labs Operational KPIs
Fifty 1 Labs' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Fifty 1 Labs Competitors
Fifty 1 Labs competitors include Crona, NxGen Brands, Olymp, Nosium, Emergent Health, Momentous Holdings, Ming Le Sports, Fitell, IMD Companies and HitIQ.
Most Fifty 1 Labs public comparables operate across Health & Beauty and Sports & Leisure.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | (37.6x) | - | |||
| - | - | - | - | |||
| 5.0x | - | (8.7x) | - | |||
| 1.5x | - | (0.9x) | - | |||
| - | - | - | - | |||
| - | - | (14.4x) | - | |||
| (438.8x) | - | 2.9x | - | |||
| - | - | - | - | |||
This data is available for Pro users. Sign up to see all Fifty 1 Labs competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Fifty 1 Labs
Fifty 1 Labs has acquired 3 companies to date.
Last acquisition by Fifty 1 Labs was on September 30th 2025. Fifty 1 Labs acquired BioSpark for undisclosed valuation.
Latest Acquisitions by Fifty 1 Labs
| Description | BioSpark is an AI-powered analytics firm based in Tel Aviv, Israel, delivering patient journey insights for oncology. It aggregates real-world data from electronic health records and claims to support pharmaceutical companies, regulators, and nonprofits in optimizing cancer treatment pathways, clinical trial design, and health policy decisions. | Genetic Networks is a computational biology firm offering target identification and drug optimization tools. Its platform integrates genetic data to deliver insights that refine decision-making, mitigate risks, and accelerate development in pharmaceuticals. The company serves biotech researchers with predictive analytics for novel therapies. | Drago Knives is a manufacturer focused on throwing knives designed for precision and durability. The company produces balanced blades suited for target practice and competitions, emphasizing ergonomic handles and high-quality steel construction. Drago models cater to enthusiasts and professionals in the sport of knife throwing. |
| HQ Country | |||
| HQ City | Tel Aviv | Miami, FL | Miami, FL |
| Deal Date | 30 Sep 2025 | 20 Mar 2025 | 18 Jun 2024 |
| Valuation | undisclosed | $10M | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Fifty 1 Labs acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fifty 1 Labs
| When was Fifty 1 Labs founded? | Fifty 1 Labs was founded in 1998. |
| Where is Fifty 1 Labs headquartered? | Fifty 1 Labs is headquartered in United States. |
| How many employees does Fifty 1 Labs have? | As of today, Fifty 1 Labs has over 10 employees. |
| Is Fifty 1 Labs publicly listed? | Yes, Fifty 1 Labs is a public company listed on OTCM. |
| What is the stock symbol of Fifty 1 Labs? | Fifty 1 Labs trades under FITY ticker. |
| When did Fifty 1 Labs go public? | Fifty 1 Labs went public in 2004. |
| Who are competitors of Fifty 1 Labs? | Fifty 1 Labs main competitors include Crona, NxGen Brands, Olymp, Nosium, Emergent Health, Momentous Holdings, Ming Le Sports, Fitell, IMD Companies, HitIQ. |
| What is the current market cap of Fifty 1 Labs? | Fifty 1 Labs' current market cap is $489K. |
| What is the current revenue of Fifty 1 Labs? | Fifty 1 Labs' last fiscal year revenue is $0K. |
| What is the current EV/Revenue multiple of Fifty 1 Labs? | Current revenue multiple of Fifty 1 Labs is 7690.3x. |
| Is Fifty 1 Labs profitable? | No, Fifty 1 Labs is not profitable. |
| How many companies Fifty 1 Labs has acquired to date? | As of June 2026, Fifty 1 Labs has acquired 3 companies. |
| What was the largest acquisition by Fifty 1 Labs? | $10M acquisition of Genetic Networks on 20th March 2025 was the largest M&A Fifty 1 Labs has done to date. |
| What companies Fifty 1 Labs acquired? | Fifty 1 Labs acquired Genetic Networks, BioSpark, and Drago Knives. |
| In how many companies Fifty 1 Labs has invested to date? | Fifty 1 Labs hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Fifty 1 Labs
Lists including Fifty 1 Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

